Comprehensive Stock Comparison
Compare Natural Health Trends Corp. (NHTC) vs Yatsen Holding Limited (YSG) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | YSG | 0.8% revenue growth vs NHTC's -7.4% |
| Quality / Margins | NHTC | -2.2% net margin vs YSG's -11.8% |
| Stability / Safety | NHTC | Beta 0.28 vs YSG's 0.93 |
| Dividends | NHTC | 25.0% yield; YSG pays no meaningful dividend |
| Momentum (1Y) | YSG | +16.8% vs NHTC's -19.8% |
| Efficiency (ROA) | NHTC | -2.3% ROA vs YSG's -11.9%, ROIC -6.5% vs -10.9% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Natural Health Trends is a direct-selling and e-commerce company that sells wellness, beauty, and lifestyle products under the NHT Global brand. It generates revenue primarily through multi-level marketing commissions — where independent distributors earn on their own sales and those in their downline — supplemented by direct e-commerce sales to consumers. The company's competitive advantage lies in its established distributor network across multiple international markets, which creates a built-in sales force and customer base.
Yatsen Holding is a Chinese beauty company that develops and sells color cosmetics, skincare, and beauty products under multiple brands including Perfect Diary, Little Ondine, and Galénic. It generates revenue primarily through direct-to-consumer online sales — via its own e-commerce platforms and third-party marketplaces — complemented by physical retail stores across China. The company's competitive advantage lies in its data-driven product development, strong digital marketing capabilities, and multi-brand portfolio that targets different consumer segments across China's beauty market.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
NHTC leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). YSG leads in 1 (Financial Metrics).
Financial Metrics (TTM)
YSG is the larger business by revenue, generating $4.1B annually — 102.3x NHTC's $40M. NHTC is the more profitable business, keeping -2.2% of every revenue dollar as net income compared to YSG's -11.8%. On growth, YSG holds the edge at +50.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | NHTCNatural Health Tr… | YSGYatsen Holding Li… |
|---|---|---|
| RevenueTrailing 12 months | $40M | $4.1B |
| EBITDAEarnings before interest/tax | -$2M | -$60M |
| Net IncomeAfter-tax profit | -$882,000 | -$479M |
| Free Cash FlowCash after capex | -$5M | $0 |
| Gross MarginGross profit ÷ Revenue | +73.5% | +78.3% |
| Operating MarginEBIT ÷ Revenue | -4.5% | -3.9% |
| Net MarginNet income ÷ Revenue | -2.2% | -11.8% |
| FCF MarginFCF ÷ Revenue | -12.4% | -8.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -10.1% | +50.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.3% | +40.7% |
Valuation Metrics
| Metric | NHTCNatural Health Tr… | YSGYatsen Holding Li… |
|---|---|---|
| Market CapShares × price | $37M | $2.7B |
| Enterprise ValueMkt cap + debt − cash | $33M | $2.6B |
| Trailing P/EPrice ÷ TTM EPS | -41.72x | -4.36x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 2.52x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.93x | 5.33x |
| Price / BookPrice ÷ Book value/share | 1.57x | 1.00x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
NHTC delivers a -3.8% return on equity — every $100 of shareholder capital generates $-4 in annual profit, vs $-16 for YSG. YSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to NHTC's 0.13x. On the Piotroski fundamental quality scale (0–9), YSG scores 4/9 vs NHTC's 2/9, reflecting mixed financial health.
| Metric | NHTCNatural Health Tr… | YSGYatsen Holding Li… |
|---|---|---|
| ROE (TTM)Return on equity | -3.8% | -15.9% |
| ROA (TTM)Return on assets | -2.3% | -11.9% |
| ROICReturn on invested capital | -6.5% | -10.9% |
| ROCEReturn on capital employed | -6.1% | -11.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 |
| Debt / EquityFinancial leverage | 0.13x | 0.05x |
| Net DebtTotal debt minus cash | -$4M | -$668M |
| Cash & Equiv.Liquid assets | $7M | $817M |
| Total DebtShort + long-term debt | $3M | $149M |
| Interest CoverageEBIT ÷ Interest expense | — | — |
Total Returns (with DRIP)
A $10,000 investment in NHTC five years ago would be worth $10,807 today (with dividends reinvested), compared to $476 for YSG. Over the past 12 months, YSG leads with a +16.8% total return vs NHTC's -19.8%. The 3-year compound annual growth rate (CAGR) favors NHTC at 2.6% vs YSG's -14.4% — a key indicator of consistent wealth creation.
| Metric | NHTCNatural Health Tr… | YSGYatsen Holding Li… |
|---|---|---|
| YTD ReturnYear-to-date | +7.1% | +5.0% |
| 1-Year ReturnPast 12 months | -19.8% | +16.8% |
| 3-Year ReturnCumulative with dividends | +8.1% | -37.3% |
| 5-Year ReturnCumulative with dividends | +8.1% | -95.2% |
| 10-Year ReturnCumulative with dividends | -56.2% | -95.2% |
| CAGR (3Y)Annualised 3-year return | +2.6% | -14.4% |
Risk & Volatility
NHTC is the less volatile stock with a 0.28 beta — it tends to amplify market swings less than YSG's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NHTC currently trades 53.3% from its 52-week high vs YSG's 38.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | NHTCNatural Health Tr… | YSGYatsen Holding Li… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.28x | 0.93x |
| 52-Week HighHighest price in past year | $6.00 | $11.57 |
| 52-Week LowLowest price in past year | $2.40 | $3.30 |
| % of 52W HighCurrent price vs 52-week peak | +53.3% | +38.5% |
| RSI (14)Momentum oscillator 0–100 | 40.3 | 61.6 |
| Avg Volume (50D)Average daily shares traded | 30K | 92K |
Analyst Outlook
NHTC is the only dividend payer here at 25.04% yield — a key consideration for income-focused portfolios.
| Metric | NHTCNatural Health Tr… | YSGYatsen Holding Li… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | 3 |
| Dividend YieldAnnual dividend ÷ price | +25.0% | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | $0.80 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.2% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Dec 20 | Feb 26 | Change |
|---|---|---|---|
| Natural Health Tren… (NHTC) | 100 | 70.97 | -29.0% |
| Yatsen Holding Limi… (YSG) | 91.2 | 4.47 | -95.1% |
Natural Health Tren… (NHTC) returned +8% over 5 years vs Yatsen Holding Limi… (YSG)'s -95%. A $10,000 investment in NHTC 5 years ago would be worth $10,807 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Natural Health Tren… (NHTC) | $288M | $40M | -86.2% |
| Yatsen Holding Limi… (YSG) | $660M | $3.4B | +421.4% |
Natural Health Trends Corp.'s revenue grew from $288M (2016) to $40M (2025) — a -19.7% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Natural Health Tren… (NHTC) | 19.1% | -2.2% | -111.6% |
| Yatsen Holding Limi… (YSG) | -6.3% | -20.9% | -230.4% |
Natural Health Trends Corp.'s net margin went from 19% (2016) to -2% (2025).
Chart 4P/E Ratio History — 7 Years
| Stock | 2017 | 2024 | Change |
|---|---|---|---|
| Natural Health Tren… (NHTC) | 7.3 | 92.8 | +1171.2% |
Natural Health Trends Corp. has traded in a 7x–125x P/E range over 7 years; current trailing P/E is ~-42x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Natural Health Tren… (NHTC) | 4.83 | -0.08 | -101.6% |
| Yatsen Holding Limi… (YSG) | -0.05 | -7 | -13157.6% |
Natural Health Trends Corp.'s EPS grew from $4.83 (2016) to $-0.08 (2025) — a NaN% CAGR.
Chart 6Free Cash Flow — 5 Years
Natural Health Trends Corp. generated $-6M FCF in 2025 (-867% vs 2021). Yatsen Holding Limited generated $-301M FCF in 2024 (+75% vs 2021).
NHTC vs YSG: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Is NHTC or YSG a better buy right now?
Analysts rate Yatsen Holding Limited (YSG) a "Hold" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NHTC or YSG?
Over the past 5 years, Natural Health Trends Corp. (NHTC) delivered a total return of +8.1%, compared to -95.2% for Yatsen Holding Limited (YSG). A $10,000 investment in NHTC five years ago would be worth approximately $11K today (assuming dividends reinvested). Over 10 years, the gap is even starker: NHTC returned -56.2% versus YSG's -95.2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NHTC or YSG?
By beta (market sensitivity over 5 years), Natural Health Trends Corp. (NHTC) is the lower-risk stock at 0.28β versus Yatsen Holding Limited's 0.93β — meaning YSG is approximately 231% more volatile than NHTC relative to the S&P 500. On balance sheet safety, Yatsen Holding Limited (YSG) carries a lower debt/equity ratio of 5% versus 13% for Natural Health Trends Corp. — giving it more financial flexibility in a downturn.
04Which has better profit margins — NHTC or YSG?
Natural Health Trends Corp. (NHTC) is the more profitable company, earning -2.2% net margin versus -20.9% for Yatsen Holding Limited — meaning it keeps -2.2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHTC leads at -4.5% versus -12.4% for YSG. At the gross margin level — before operating expenses — YSG leads at 77.1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — NHTC or YSG?
In this comparison, NHTC (25.0% yield) pays a dividend. YSG does not pay a meaningful dividend and should not be held primarily for income.
06Is NHTC or YSG better for a retirement portfolio?
For long-horizon retirement investors, Natural Health Trends Corp. (NHTC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.28), 25.0% yield). Both have compounded well over 10 years (NHTC: -56.2%, YSG: -95.2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between NHTC and YSG?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: NHTC is a small-cap income-oriented stock; YSG is a small-cap quality compounder stock. NHTC pays a dividend while YSG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.